Finolex Cables Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 8:01 am

Competitors of Finolex Cables Ltd

All Competitor Stocks of Finolex Cables Ltd

Quarterly Result

Last Updated: August 20, 2025, 10:55 am

Below is a detailed analysis of the quarterly data for Finolex Cables Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,396.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,595.00 Cr. (Mar 2025) to 1,396.00 Cr., marking a decrease of 199.00 Cr..
• For Expenses, as of Jun 2025, the value is 1,265.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,428.00 Cr. (Mar 2025) to 1,265.00 Cr., marking a decrease of 163.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 131.00 Cr.. The value appears to be declining and may need further review. It has decreased from 166.00 Cr. (Mar 2025) to 131.00 Cr., marking a decrease of 35.00 Cr..
• For OPM %, as of Jun 2025, the value is 9.00%. The value appears to be declining and may need further review. It has decreased from 10.00% (Mar 2025) to 9.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 54.00 Cr.. The value appears to be declining and may need further review. It has decreased from 55.00 Cr. (Mar 2025) to 54.00 Cr., marking a decrease of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Depreciation, as of Jun 2025, the value is 14.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 171.00 Cr.. The value appears to be declining and may need further review. It has decreased from 208.00 Cr. (Mar 2025) to 171.00 Cr., marking a decrease of 37.00 Cr..
• For Tax %, as of Jun 2025, the value is 19.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 19.00%, marking a decrease of 8.00%.
• For Net Profit, as of Jun 2025, the value is 139.00 Cr.. The value appears to be declining and may need further review. It has decreased from 152.00 Cr. (Mar 2025) to 139.00 Cr., marking a decrease of 13.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 9.08. The value appears to be declining and may need further review. It has decreased from 9.93 (Mar 2025) to 9.08, marking a decrease of 0.85.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:24 am

Growth

Last Updated: September 5, 2025, 4:00 am

Balance Sheet

Last Updated: September 10, 2025, 1:42 pm

Below is a detailed analysis of the balance sheet data for Finolex Cables Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 31.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 31.00 Cr..
• For Reserves, as of Mar 2025, the value is 4,569.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,175.00 Cr. (Mar 2024) to 4,569.00 Cr., marking an increase of 394.00 Cr..
• For Borrowings, as of Mar 2025, the value is 20.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 18.00 Cr. (Mar 2024) to 20.00 Cr., marking an increase of 2.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 451.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 404.00 Cr. (Mar 2024) to 451.00 Cr., marking an increase of 47.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 5,071.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,628.00 Cr. (Mar 2024) to 5,071.00 Cr., marking an increase of 443.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 583.00 Cr.. The value appears strong and on an upward trend. It has increased from 444.00 Cr. (Mar 2024) to 583.00 Cr., marking an increase of 139.00 Cr..
• For CWIP, as of Mar 2025, the value is 210.00 Cr.. The value appears strong and on an upward trend. It has increased from 168.00 Cr. (Mar 2024) to 210.00 Cr., marking an increase of 42.00 Cr..
• For Investments, as of Mar 2025, the value is 2,770.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,576.00 Cr. (Mar 2024) to 2,770.00 Cr., marking an increase of 194.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,507.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,439.00 Cr. (Mar 2024) to 1,507.00 Cr., marking an increase of 68.00 Cr..
• For Total Assets, as of Mar 2025, the value is 5,071.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,628.00 Cr. (Mar 2024) to 5,071.00 Cr., marking an increase of 443.00 Cr..

Notably, the Reserves (4,569.00 Cr.) exceed the Borrowings (20.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Finolex Cables Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 45.82. This value is within the healthy range. It has increased from 42.61 (Mar 24) to 45.82, marking an increase of 3.21.
• For Diluted EPS (Rs.), as of Mar 25, the value is 45.82. This value is within the healthy range. It has increased from 42.61 (Mar 24) to 45.82, marking an increase of 3.21.
• For Cash EPS (Rs.), as of Mar 25, the value is 33.69. This value is within the healthy range. It has decreased from 35.92 (Mar 24) to 33.69, marking a decrease of 2.23.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 359.28. It has increased from 323.36 (Mar 24) to 359.28, marking an increase of 35.92.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 359.28. It has increased from 323.36 (Mar 24) to 359.28, marking an increase of 35.92.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 347.75. It has increased from 327.85 (Mar 24) to 347.75, marking an increase of 19.90.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 48.30. This value is within the healthy range. It has decreased from 49.92 (Mar 24) to 48.30, marking a decrease of 1.62.
• For PBIT / Share (Rs.), as of Mar 25, the value is 45.25. This value is within the healthy range. It has decreased from 47.05 (Mar 24) to 45.25, marking a decrease of 1.80.
• For PBT / Share (Rs.), as of Mar 25, the value is 45.14. This value is within the healthy range. It has decreased from 46.92 (Mar 24) to 45.14, marking a decrease of 1.78.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 30.65. This value is within the healthy range. It has decreased from 33.05 (Mar 24) to 30.65, marking a decrease of 2.40.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 45.82. This value is within the healthy range. It has increased from 42.61 (Mar 24) to 45.82, marking an increase of 3.21.
• For PBDIT Margin (%), as of Mar 25, the value is 13.88. This value is within the healthy range. It has decreased from 15.22 (Mar 24) to 13.88, marking a decrease of 1.34.
• For PBIT Margin (%), as of Mar 25, the value is 13.01. This value is within the healthy range. It has decreased from 14.35 (Mar 24) to 13.01, marking a decrease of 1.34.
• For PBT Margin (%), as of Mar 25, the value is 12.98. This value is within the healthy range. It has decreased from 14.31 (Mar 24) to 12.98, marking a decrease of 1.33.
• For Net Profit Margin (%), as of Mar 25, the value is 8.81. This value is within the healthy range. It has decreased from 10.08 (Mar 24) to 8.81, marking a decrease of 1.27.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 13.17. This value is within the healthy range. It has increased from 12.99 (Mar 24) to 13.17, marking an increase of 0.18.
• For Return on Networth / Equity (%), as of Mar 25, the value is 12.75. This value is below the healthy minimum of 15. It has decreased from 13.17 (Mar 24) to 12.75, marking a decrease of 0.42.
• For Return on Capital Employeed (%), as of Mar 25, the value is 11.21. This value is within the healthy range. It has decreased from 13.58 (Mar 24) to 11.21, marking a decrease of 2.37.
• For Return On Assets (%), as of Mar 25, the value is 11.14. This value is within the healthy range. It has decreased from 11.56 (Mar 24) to 11.14, marking a decrease of 0.42.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.89. It has decreased from 0.94 (Mar 24) to 0.89, marking a decrease of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 33.12. This value exceeds the healthy maximum of 3. It has increased from 10.56 (Mar 24) to 33.12, marking an increase of 22.56.
• For Quick Ratio (X), as of Mar 25, the value is 26.84. This value exceeds the healthy maximum of 2. It has increased from 8.84 (Mar 24) to 26.84, marking an increase of 18.00.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.74. This value is within the healthy range. It has increased from 6.10 (Mar 24) to 6.74, marking an increase of 0.64.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 16.42 (Mar 24) to 0.00, marking a decrease of 16.42.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 15.39 (Mar 24) to 0.00, marking a decrease of 15.39.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 83.58 (Mar 24) to 0.00, marking a decrease of 83.58.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 84.61 (Mar 24) to 0.00, marking a decrease of 84.61.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 442.34. This value is within the healthy range. It has increased from 376.13 (Mar 24) to 442.34, marking an increase of 66.21.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 281.68. This value is within the healthy range. It has increased from 250.05 (Mar 24) to 281.68, marking an increase of 31.63.
• For Enterprise Value (Cr.), as of Mar 25, the value is 13,913.31. It has decreased from 15,210.13 (Mar 24) to 13,913.31, marking a decrease of 1,296.82.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.62. This value is within the healthy range. It has decreased from 3.03 (Mar 24) to 2.62, marking a decrease of 0.41.
• For EV / EBITDA (X), as of Mar 25, the value is 18.83. This value exceeds the healthy maximum of 15. It has decreased from 19.92 (Mar 24) to 18.83, marking a decrease of 1.09.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.63. This value is within the healthy range. It has decreased from 3.05 (Mar 24) to 2.63, marking a decrease of 0.42.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 83.57 (Mar 24) to 0.00, marking a decrease of 83.57.
• For Price / BV (X), as of Mar 25, the value is 2.54. This value is within the healthy range. It has decreased from 3.09 (Mar 24) to 2.54, marking a decrease of 0.55.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.63. This value is within the healthy range. It has decreased from 3.05 (Mar 24) to 2.63, marking a decrease of 0.42.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness